Tricuspid valve repair using a new replacement valve patch
Part of Heart & circulation clinical trials.
This trial studies a new valve replacement device (the Cor TRICUSPID ECM Valve) for people whose right-sided tricuspid valve is leaking or missing and needs surgery. It may help restore proper one-way blood flow in the heart, but you must meet several heart, blood, and organ-health requirements.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You need surgery because your tricuspid valve is leaking or absent
- The replacement must be for the right-sided heart valve (not the left or “systemic” valve)
- Your heart size/structure must fit the device (the valve opening must be at least 10 mm)
- Your lung pressures must not be too high (and blood-vessel resistance must be limited)
- Your blood can be safely managed for the required blood-thinning medicines
- You can attend required follow-up visits and your doctor can consent for the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a special replacement valve (an “ECM valve”) for people whose tricuspid valve is leaky or missing and needs surgery. It may help restore blood flow on the right side of the heart and is designed for certain children born with congenital heart problems.
This trial tests a catheter-based procedure (done through the blood vessels) to repair a severely leaky tricuspid valve. It may help people with symptoms or past hospitalizations from tricuspid valve leakage who are higher-risk for standard surgery.
This trial tests a new device called TricValve, which is placed through a catheter (a thin tube) to fix a leaky tricuspid valve on the right side of the heart. It aims to reduce blood flowing backward and improve heart failure symptoms for people who can't have open-heart surgery and haven't been helped by other catheter treatments.
This study tests a new way to repair the tricuspid valve (the valve that controls blood flow on the right side of your heart) using a piece of your own heart tissue called the right atrial appendage. This might be an option for people who need this type of valve surgery.
This trial tests a new device called the Laplace system, which replaces the tricuspid valve in your heart without open-heart surgery. It is designed for people with severe tricuspid regurgitation (a leaky heart valve) who still have symptoms despite taking medications.
This trial tests a new catheter-based procedure that replaces the tricuspid valve to reduce severe valve leaking. It may help people who still have symptoms despite heart medicines, but only if their heart shape and other health details fit the device requirements.
Hear when a new Tricuspid Valve Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.